Cite
HARVARD Citation
Widemann, B. et al. (n.d.). Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Neuro-oncology. 16 (5), pp. 707-718. [Online].